It was determined that overexpression of miR-26b-5p disrupts the TGFβ/SMAD signaling pathway in CLL cells by targeting SMAD4 gene, leading to a reduction expression of p21-Cip1 kinase inhibitor and increased expression of c-MYC. The gene discussed is MYC; the disease is B-cell chronic lymphocytic leukemia.